|
|
regulation of mrna processing
|
GO:0050684 |
41 |
0.681
|
Fly |
|
|
mrna metabolic process
|
GO:0016071 |
84 |
0.643
|
Fly |
|
|
pole plasm assembly
|
GO:0007315 |
2 |
0.498
|
|
|
|
rna splicing via transesterification reactions with bulged adenosine as nucleophile
|
GO:0000377 |
43 |
0.480
|
Fly |
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.480
|
Mouse |
|
|
germ cell development
|
GO:0007281 |
185 |
0.367
|
Mouse |
|
|
rna splicing
|
GO:0008380 |
54 |
0.362
|
Fly |
|
|
rna splicing via transesterification reactions
|
GO:0000375 |
43 |
0.317
|
Fly |
|
|
oocyte construction
|
GO:0007308 |
2 |
0.295
|
|
|
|
intracellular mrna localization
|
GO:0008298 |
4 |
0.277
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.270
|
|
|
|
regulation of mrna metabolic process
|
GO:1903311 |
43 |
0.261
|
Fly |
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.248
|
|
|
|
mrna splicing via spliceosome
|
GO:0000398 |
43 |
0.225
|
Fly |
|
|
regulation of actin filament length
|
GO:0030832 |
45 |
0.219
|
|
|
|
alternative mrna splicing via spliceosome
|
GO:0000380 |
12 |
0.218
|
Fly |
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.192
|
Mouse |
|
|
development of primary sexual characteristics
|
GO:0045137 |
143 |
0.192
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.191
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.190
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.186
|
|
|
|
regulation of mrna stability
|
GO:0043488 |
23 |
0.179
|
Mouse |
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.175
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.167
|
Mouse |
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.163
|
|
|
|
rna processing
|
GO:0006396 |
105 |
0.162
|
Fly |
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.162
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.160
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.158
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.155
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.155
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.145
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.142
|
Human Mouse |
|
|
mrna processing
|
GO:0006397 |
63 |
0.141
|
Fly |
|
|
olfactory learning
|
GO:0008355 |
2 |
0.135
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.135
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.133
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.132
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.131
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.131
|
|
|
|
oocyte anterior posterior axis specification
|
GO:0007314 |
2 |
0.131
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.130
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.129
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.122
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.121
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
83 |
0.117
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.117
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.117
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.115
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.114
|
|
|
|
positive regulation of podosome assembly
|
GO:0071803 |
3 |
0.110
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.110
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.109
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.104
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.103
|
|
|
|
negative regulation of phosphorylation
|
GO:0042326 |
166 |
0.100
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.100
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.098
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.097
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.096
|
|
|
|
organelle fission
|
GO:0048285 |
170 |
0.095
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
139 |
0.095
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.093
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.093
|
|
|
|
regulation of rna splicing
|
GO:0043484 |
37 |
0.092
|
Fly |
|
|
inflammatory response
|
GO:0006954 |
244 |
0.092
|
|
|
|
positive regulation of mrna metabolic process
|
GO:1903313 |
17 |
0.092
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.091
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.091
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.090
|
|
|
|
regulation of jak stat cascade
|
GO:0046425 |
34 |
0.089
|
|
|
|
regulation of synaptic growth at neuromuscular junction
|
GO:0008582 |
4 |
0.089
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.088
|
Mouse |
|
|
developmental maturation
|
GO:0021700 |
193 |
0.088
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.087
|
|
|
|
cellularization
|
GO:0007349 |
1 |
0.086
|
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.085
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.084
|
|
|
|
cellular response to organonitrogen compound
|
GO:0071417 |
145 |
0.084
|
|
|
|
regulation of hematopoietic progenitor cell differentiation
|
GO:1901532 |
18 |
0.081
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.079
|
|
|
|
gonad development
|
GO:0008406 |
141 |
0.079
|
|
|
|
positive regulation of rna splicing
|
GO:0033120 |
12 |
0.078
|
|
|
|
oocyte development
|
GO:0048599 |
33 |
0.078
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.077
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.077
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.076
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.076
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.076
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.075
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.075
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.073
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.073
|
|
|
|
regulation of antigen receptor mediated signaling pathway
|
GO:0050854 |
29 |
0.073
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.072
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.071
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.071
|
|
|
|
regulation of mrna splicing via spliceosome
|
GO:0048024 |
32 |
0.071
|
Fly |
|
|
negative regulation of myeloid cell differentiation
|
GO:0045638 |
38 |
0.070
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.069
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.069
|
|
|
|
regulation of ras protein signal transduction
|
GO:0046578 |
114 |
0.068
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.068
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.068
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.068
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.067
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.067
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.067
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.065
|
|
|
|
translation
|
GO:0006412 |
93 |
0.065
|
Human |
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.065
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.065
|
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.065
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.064
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.064
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.064
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.064
|
|
|
|
cellular response to peptide
|
GO:1901653 |
92 |
0.063
|
|
|
|
regulation of insulin receptor signaling pathway
|
GO:0046626 |
21 |
0.062
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.062
|
|
|
|
establishment or maintenance of cell polarity
|
GO:0007163 |
86 |
0.062
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.062
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.061
|
|
|
|
female gamete generation
|
GO:0007292 |
74 |
0.061
|
|
|
|
cellular response to insulin stimulus
|
GO:0032869 |
78 |
0.061
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.060
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.060
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.059
|
|
|
|
oocyte differentiation
|
GO:0009994 |
35 |
0.059
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.059
|
|
|
|
positive regulation of b cell receptor signaling pathway
|
GO:0050861 |
4 |
0.059
|
|
|
|
nuclear division
|
GO:0000280 |
158 |
0.058
|
|
|
|
positive regulation of mrna splicing via spliceosome
|
GO:0048026 |
11 |
0.058
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.058
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.058
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.057
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.057
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.056
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.056
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.055
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.055
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.054
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.054
|
|
|
|
calcium ion transport
|
GO:0006816 |
159 |
0.053
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.053
|
|
|
|
segmentation
|
GO:0035282 |
93 |
0.053
|
|
|
|
regulation of alternative mrna splicing via spliceosome
|
GO:0000381 |
8 |
0.053
|
Fly |
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.052
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.052
|
|
|
|
regulation of intracellular estrogen receptor signaling pathway
|
GO:0033146 |
8 |
0.052
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.052
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.052
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.052
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.052
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.052
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
94 |
0.052
|
|
|
|
negative regulation of rna splicing
|
GO:0033119 |
12 |
0.052
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.052
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.052
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.051
|
|
|
|
rna catabolic process
|
GO:0006401 |
29 |
0.051
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.051
|
|
|
|
regulation of organelle assembly
|
GO:1902115 |
19 |
0.050
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.050
|
|
|
|
rna stabilization
|
GO:0043489 |
9 |
0.050
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.050
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.049
|
|
|
|
negative regulation of mrna processing
|
GO:0050686 |
12 |
0.049
|
|
|
|
positive regulation of synaptic growth at neuromuscular junction
|
GO:0045887 |
1 |
0.049
|
|
|
|
meiotic nuclear division
|
GO:0007126 |
115 |
0.049
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.049
|
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.049
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.048
|
|
|
|
positive regulation of erk1 and erk2 cascade
|
GO:0070374 |
47 |
0.048
|
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.048
|
|
|
|
maternal determination of anterior posterior axis embryo
|
GO:0008358 |
2 |
0.047
|
|
|
|
sequestering of calcium ion
|
GO:0051208 |
18 |
0.047
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.047
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.047
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.047
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.047
|
|
|
|
ribonucleoprotein complex subunit organization
|
GO:0071826 |
28 |
0.047
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.047
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.046
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.046
|
|
|
|
regulation of myeloid cell differentiation
|
GO:0045637 |
96 |
0.046
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.046
|
|
|
|
actin filament polymerization
|
GO:0030041 |
44 |
0.045
|
|
|
|
i kappab kinase nf kappab signaling
|
GO:0007249 |
85 |
0.045
|
|
|
|
positive regulation of leukocyte mediated immunity
|
GO:0002705 |
70 |
0.045
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.045
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.044
|
|
|
|
regulation of protein binding
|
GO:0043393 |
60 |
0.044
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.044
|
|
|
|
regulation of endocytosis
|
GO:0030100 |
69 |
0.043
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.043
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.043
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.043
|
|
|
|
regulation of actin polymerization or depolymerization
|
GO:0008064 |
45 |
0.043
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.042
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.042
|
|
|
|
activation of phospholipase c activity
|
GO:0007202 |
2 |
0.042
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.042
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.041
|
|
|
|
megakaryocyte differentiation
|
GO:0030219 |
26 |
0.041
|
|
|
|
canonical wnt signaling pathway
|
GO:0060070 |
130 |
0.041
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.041
|
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.041
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.040
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.040
|
|
|
|
mrna stabilization
|
GO:0048255 |
9 |
0.039
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.039
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.039
|
|
|
|
negative regulation of insulin receptor signaling pathway
|
GO:0046627 |
14 |
0.039
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.039
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.039
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.039
|
|
|
|
release of sequestered calcium ion into cytosol
|
GO:0051209 |
42 |
0.038
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.038
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.037
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.037
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.037
|
|
|
|
negative regulation of protein phosphorylation
|
GO:0001933 |
126 |
0.037
|
|
|
|
response to ethanol
|
GO:0045471 |
18 |
0.036
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.036
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.036
|
|
|
|
nuclear export
|
GO:0051168 |
34 |
0.036
|
|
|
|
regulation of lymphocyte differentiation
|
GO:0045619 |
107 |
0.036
|
|
|
|
regulation of b cell differentiation
|
GO:0045577 |
23 |
0.036
|
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.036
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.036
|
|
|
|
regulation of podosome assembly
|
GO:0071801 |
3 |
0.035
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.035
|
|
|
|
negative regulation of mrna metabolic process
|
GO:1903312 |
13 |
0.035
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.035
|
|
|
|
regulation of cytoplasmic transport
|
GO:1903649 |
112 |
0.035
|
|
|
|
positive regulation of phospholipase c activity
|
GO:0010863 |
2 |
0.035
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.035
|
|
|
|
insulin receptor signaling pathway
|
GO:0008286 |
49 |
0.035
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.035
|
|
|
|
dendritic cell apoptotic process
|
GO:0097048 |
3 |
0.035
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.035
|
|
|
|
protein polymerization
|
GO:0051258 |
57 |
0.035
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.035
|
|
|
|
negative regulation of mrna splicing via spliceosome
|
GO:0048025 |
12 |
0.034
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.034
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.034
|
|
|
|
regulation of rna stability
|
GO:0043487 |
26 |
0.034
|
Mouse |
|
|
intracellular receptor signaling pathway
|
GO:0030522 |
74 |
0.034
|
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.034
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.034
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.033
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.033
|
|
|
|
sequestering of metal ion
|
GO:0051238 |
19 |
0.033
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.033
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.033
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.033
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.032
|
|
|
|
response to alcohol
|
GO:0097305 |
48 |
0.032
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.032
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.032
|
|
|
|
negative regulation of mast cell proliferation
|
GO:0070667 |
1 |
0.032
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.032
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.032
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.032
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.031
|
|
|
|
regulation of mast cell activation
|
GO:0033003 |
21 |
0.031
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.031
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.031
|
|
|
|
negative regulation of b cell activation
|
GO:0050869 |
27 |
0.031
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.031
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.031
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.031
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.031
|
|
|
|
cellular response to lipopolysaccharide
|
GO:0071222 |
77 |
0.031
|
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.031
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
148 |
0.030
|
|
|
|
regulation of toll like receptor 2 signaling pathway
|
GO:0034135 |
3 |
0.030
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.030
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.029
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.029
|
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.029
|
|
|
|
regulation of neuron projection development
|
GO:0010975 |
169 |
0.029
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.029
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
|
regulation of leukocyte mediated immunity
|
GO:0002703 |
104 |
0.029
|
|
|
|
regulation of ion homeostasis
|
GO:2000021 |
64 |
0.028
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.028
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.028
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.028
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.028
|
|
|
|
negative regulation of cellular response to insulin stimulus
|
GO:1900077 |
16 |
0.028
|
|
|
|
positive regulation of immune effector process
|
GO:0002699 |
107 |
0.028
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
70 |
0.028
|
Human |
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.028
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.027
|
Mouse |
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.027
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.027
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.027
|
|
|
|
3 utr mediated mrna stabilization
|
GO:0070935 |
2 |
0.027
|
|
|
|
regulation of canonical wnt signaling pathway
|
GO:0060828 |
82 |
0.027
|
|
|
|
cell fate specification
|
GO:0001708 |
72 |
0.027
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.027
|
|
|
|
immune response inhibiting cell surface receptor signaling pathway
|
GO:0002767 |
3 |
0.026
|
|
|
|
regulation of ras gtpase activity
|
GO:0032318 |
88 |
0.026
|
|
|
|
epithelial to mesenchymal transition
|
GO:0001837 |
47 |
0.026
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
93 |
0.026
|
|
|
|
leukocyte mediated immunity
|
GO:0002443 |
174 |
0.026
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.026
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
61 |
0.026
|
|
|
|
negative regulation of protein complex disassembly
|
GO:0043242 |
22 |
0.026
|
|
|
|
positive regulation of cell activation
|
GO:0050867 |
158 |
0.026
|
|
|
|
positive regulation of binding
|
GO:0051099 |
49 |
0.026
|
|
|
|
actin polymerization or depolymerization
|
GO:0008154 |
54 |
0.026
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.026
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.026
|
|
|
|
immune response inhibiting signal transduction
|
GO:0002765 |
4 |
0.025
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.025
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.025
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.025
|
|
|
|
rna interference
|
GO:0016246 |
2 |
0.025
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.025
|
|
|
|
maternal placenta development
|
GO:0001893 |
20 |
0.025
|
|
|
|
activation of immune response
|
GO:0002253 |
138 |
0.025
|
|
|
|
mrna catabolic process
|
GO:0006402 |
22 |
0.025
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.024
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
206 |
0.024
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.024
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.024
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.024
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.024
|
|
|
|
positive regulation of t cell activation
|
GO:0050870 |
101 |
0.024
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.024
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.024
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.024
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.024
|
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.024
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.024
|
|
|
|
regulation of dendritic cell apoptotic process
|
GO:2000668 |
3 |
0.023
|
|
|
|
positive regulation of adaptive immune response
|
GO:0002821 |
61 |
0.023
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.023
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.023
|
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.023
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.023
|
Human |
|
|
convergent extension
|
GO:0060026 |
14 |
0.023
|
|
|
|
negative regulation of toll like receptor 2 signaling pathway
|
GO:0034136 |
3 |
0.023
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.023
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.023
|
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.023
|
|
|
|
fc receptor mediated inhibitory signaling pathway
|
GO:0002774 |
1 |
0.023
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.023
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.023
|
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.023
|
Mouse |
|
|
humoral immune response
|
GO:0006959 |
57 |
0.022
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.022
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.022
|
|
|
|
positive regulation of leukocyte differentiation
|
GO:1902107 |
86 |
0.022
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.022
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.022
|
|
|
|
regulation of intracellular steroid hormone receptor signaling pathway
|
GO:0033143 |
18 |
0.022
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.022
|
|
|
|
positive regulation of mrna processing
|
GO:0050685 |
16 |
0.022
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.022
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.022
|
|
|
|
positive regulation of intracellular estrogen receptor signaling pathway
|
GO:0033148 |
4 |
0.022
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.022
|
|
|
|
cellular response to transforming growth factor beta stimulus
|
GO:0071560 |
88 |
0.022
|
|
|
|
negative regulation of map kinase activity
|
GO:0043407 |
34 |
0.022
|
|
|
|
positive regulation of myeloid leukocyte mediated immunity
|
GO:0002888 |
14 |
0.022
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.021
|
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.021
|
|
|
|
protein complex disassembly
|
GO:0043241 |
40 |
0.021
|
|
|
|
positive regulation of dna templated transcription elongation
|
GO:0032786 |
2 |
0.021
|
|
|
|
t cell differentiation in thymus
|
GO:0033077 |
77 |
0.021
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.021
|
|
|
|
regulation of actin filament polymerization
|
GO:0030833 |
38 |
0.021
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.021
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.020
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.020
|
|
|
|
regulation of phospholipase c activity
|
GO:1900274 |
3 |
0.020
|
|
|
|
dna templated transcription termination
|
GO:0006353 |
4 |
0.020
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.020
|
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.020
|
|
|
|
nuclear transcribed mrna catabolic process nonsense mediated decay
|
GO:0000184 |
1 |
0.020
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.020
|
|
|
|
negative regulation of mapk cascade
|
GO:0043409 |
65 |
0.020
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.020
|
|
|
|
cell junction assembly
|
GO:0034329 |
52 |
0.020
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
159 |
0.019
|
|
|
|
negative regulation of transferase activity
|
GO:0051348 |
85 |
0.019
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.019
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.019
|
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.019
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.019
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.019
|
|
|
|
cytosolic calcium ion homeostasis
|
GO:0051480 |
70 |
0.019
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.019
|
Mouse |
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.019
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.019
|
|
|
|
immune response regulating cell surface receptor signaling pathway
|
GO:0002768 |
80 |
0.019
|
|
|
|
positive regulation of dendritic cell apoptotic process
|
GO:2000670 |
3 |
0.019
|
|
|
|
regulation of leukocyte degranulation
|
GO:0043300 |
20 |
0.019
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.019
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.019
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.019
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.019
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.019
|
|
|
|
lymphocyte apoptotic process
|
GO:0070227 |
54 |
0.018
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.018
|
|
|
|
nucleobase containing compound transport
|
GO:0015931 |
27 |
0.018
|
|
|
|
phospholipid metabolic process
|
GO:0006644 |
87 |
0.018
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.018
|
|
|
|
positive regulation of lymphocyte differentiation
|
GO:0045621 |
61 |
0.018
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.018
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.018
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.018
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.018
|
|
|
|
regulation of lymphocyte apoptotic process
|
GO:0070228 |
41 |
0.018
|
|
|
|
negative regulation of myeloid leukocyte differentiation
|
GO:0002762 |
20 |
0.018
|
|
|
|
leukocyte activation involved in immune response
|
GO:0002366 |
126 |
0.018
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.018
|
|
|
|
regulation of b cell activation
|
GO:0050864 |
81 |
0.018
|
|
|
|
nucleoside phosphate biosynthetic process
|
GO:1901293 |
79 |
0.018
|
|
|
|
histone modification
|
GO:0016570 |
159 |
0.018
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.018
|
|
|
|
positive regulation of cytokine production
|
GO:0001819 |
174 |
0.017
|
|
|
|
cellular response to molecule of bacterial origin
|
GO:0071219 |
83 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.017
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.017
|
|
|
|
regulation of cell projection assembly
|
GO:0060491 |
38 |
0.017
|
|
|
|
regulation of protein complex disassembly
|
GO:0043244 |
28 |
0.017
|
|
|
|
regulation of toll like receptor 4 signaling pathway
|
GO:0034143 |
4 |
0.017
|
|
|
|
maternal process involved in female pregnancy
|
GO:0060135 |
32 |
0.017
|
|
|
|
positive regulation of proteolysis
|
GO:0045862 |
85 |
0.017
|
|
|
|
pigmentation
|
GO:0043473 |
71 |
0.017
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.017
|
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.017
|
|
|
|
immune response regulating signaling pathway
|
GO:0002764 |
125 |
0.017
|
|
|
|
regulation of gamma delta t cell activation
|
GO:0046643 |
9 |
0.017
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.017
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.017
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.016
|
|
|
|
tolerance induction to self antigen
|
GO:0002513 |
4 |
0.016
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
61 |
0.016
|
|
|
|
negative regulation of ras protein signal transduction
|
GO:0046580 |
18 |
0.016
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.016
|
|
|
|
positive regulation of neuron projection development
|
GO:0010976 |
79 |
0.016
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.016
|
|
|
|
embryonic axis specification
|
GO:0000578 |
30 |
0.016
|
|
|
|
regulation of phosphatidylinositol 3 kinase activity
|
GO:0043551 |
14 |
0.016
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.016
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.016
|
|
|
|
mammary gland morphogenesis
|
GO:0060443 |
54 |
0.016
|
|
|
|
positive regulation of phospholipase activity
|
GO:0010518 |
3 |
0.016
|
|
|
|
defense response to other organism
|
GO:0098542 |
197 |
0.016
|
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.016
|
|
|
|
synapse assembly
|
GO:0007416 |
56 |
0.016
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.016
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.015
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.015
|
|
|
|
positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002824 |
61 |
0.015
|
|
|
|
negative regulation of homeostatic process
|
GO:0032845 |
71 |
0.015
|
|
|
|
regulation of homotypic cell cell adhesion
|
GO:0034110 |
13 |
0.015
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.015
|
|
|
|
heterochromatin assembly
|
GO:0031507 |
2 |
0.015
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.015
|
|
|
|
positive regulation of t cell differentiation
|
GO:0045582 |
52 |
0.015
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.015
|
|
|
|
neuron projection extension
|
GO:1990138 |
64 |
0.015
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.015
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.015
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.015
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.015
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
92 |
0.015
|
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.015
|
|
|
|
positive regulation of nucleocytoplasmic transport
|
GO:0046824 |
30 |
0.015
|
Human |
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.015
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.015
|
|
|
|
gamma delta t cell activation
|
GO:0046629 |
13 |
0.015
|
|
|
|
detection of mechanical stimulus
|
GO:0050982 |
27 |
0.015
|
|
|
|
mesenchymal cell development
|
GO:0014031 |
93 |
0.015
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.015
|
|
|
|
positive regulation of megakaryocyte differentiation
|
GO:0045654 |
4 |
0.015
|
|
|
|
defense response to bacterium
|
GO:0042742 |
119 |
0.014
|
|
|
|
filtration diaphragm assembly
|
GO:0036058 |
1 |
0.014
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.014
|
|
|
|
positive regulation of t cell mediated immunity
|
GO:0002711 |
24 |
0.014
|
|
|
|
regulation of t cell differentiation
|
GO:0045580 |
83 |
0.014
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.014
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.014
|
|
|
|
positive regulation of lipid kinase activity
|
GO:0090218 |
11 |
0.014
|
|
